78.21
price down icon2.60%   -2.09
after-market After Hours: 79.77 1.56 +1.99%
loading
Illumina Inc stock is traded at $78.21, with a volume of 3.76M. It is down -2.60% in the last 24 hours and up +4.20% over the past month. Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
See More
Previous Close:
$80.30
Open:
$80.3
24h Volume:
3.76M
Relative Volume:
1.47
Market Cap:
$12.09B
Revenue:
$4.34B
Net Income/Loss:
$-965.00M
P/E Ratio:
-12.88
EPS:
-6.07
Net Cash Flow:
$869.00M
1W Performance:
+2.44%
1M Performance:
+4.20%
6M Performance:
-45.02%
1Y Performance:
-32.33%
1-Day Range:
Value
$77.50
$81.64
1-Week Range:
Value
$75.24
$83.09
52-Week Range:
Value
$68.70
$156.66

Illumina Inc Stock (ILMN) Company Profile

Name
Name
Illumina Inc
Name
Phone
(858) 202-4500
Name
Address
5200 ILLUMINA WAY, SAN DIEGO, CA
Name
Employee
8,970
Name
Twitter
@illumina
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
ILMN's Discussions on Twitter

Compare ILMN with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
ILMN
Illumina Inc
78.21 12.09B 4.34B -965.00M 869.00M -6.07
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
406.05 153.96B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
187.82 138.19B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
509.42 39.13B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.52 30.65B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
141.82 26.52B 15.50B 1.33B 2.16B 7.34

Illumina Inc Stock (ILMN) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-04-25 Reiterated Citigroup Neutral
Feb-28-25 Downgrade HSBC Securities Buy → Hold
Feb-10-25 Downgrade Barclays Equal Weight → Underweight
Feb-07-25 Downgrade TD Cowen Buy → Hold
Dec-11-24 Downgrade Citigroup Buy → Neutral
Nov-12-24 Resumed Morgan Stanley Equal-Weight
Oct-17-24 Upgrade HSBC Securities Hold → Buy
Aug-28-24 Upgrade Argus Hold → Buy
Aug-16-24 Upgrade Daiwa Securities Neutral → Buy
Aug-14-24 Upgrade Barclays Underweight → Equal Weight
Aug-14-24 Upgrade TD Cowen Hold → Buy
Jul-10-24 Upgrade Citigroup Neutral → Buy
Jun-03-24 Resumed Jefferies Hold
Jan-16-24 Downgrade HSBC Securities Buy → Hold
Jan-04-24 Downgrade TD Cowen Outperform → Market Perform
Dec-18-23 Upgrade Scotiabank Sector Perform → Sector Outperform
Dec-15-23 Upgrade Bernstein Underperform → Mkt Perform
Dec-14-23 Initiated Guggenheim Buy
Dec-14-23 Initiated Stephens Overweight
Dec-13-23 Initiated Wolfe Research Outperform
Dec-12-23 Downgrade BofA Securities Neutral → Underperform
Dec-11-23 Upgrade Citigroup Sell → Neutral
Nov-10-23 Downgrade Canaccord Genuity Buy → Hold
Sep-28-23 Initiated Bernstein Underperform
Jul-05-23 Resumed JP Morgan Neutral
Jan-25-23 Downgrade Argus Buy → Hold
Jan-05-23 Initiated Scotiabank Sector Perform
Dec-12-22 Downgrade Citigroup Neutral → Sell
Dec-07-22 Initiated RBC Capital Mkts Outperform
Oct-04-22 Upgrade SVB Leerink Mkt Perform → Outperform
Sep-28-22 Upgrade Evercore ISI In-line → Outperform
Aug-25-22 Initiated Credit Suisse Neutral
Jul-13-22 Downgrade Barclays Equal Weight → Underweight
Jan-18-22 Upgrade Stifel Hold → Buy
Jan-11-22 Upgrade Barclays Underweight → Equal Weight
Jan-07-22 Upgrade BofA Securities Underperform → Neutral
Jan-06-22 Resumed Morgan Stanley Equal-Weight
Jan-06-22 Resumed Piper Sandler Overweight
Oct-15-21 Resumed Cowen Outperform
Aug-19-21 Downgrade SVB Leerink Outperform → Mkt Perform
Jun-01-21 Upgrade Evercore ISI Underperform → In-line
Mar-31-21 Downgrade Atlantic Equities Overweight → Neutral
Mar-31-21 Upgrade Canaccord Genuity Hold → Buy
Mar-03-21 Initiated Barclays Underweight
Dec-22-20 Upgrade Piper Sandler Neutral → Overweight
Dec-17-20 Upgrade BTIG Research Neutral → Buy
Oct-13-20 Downgrade Guggenheim Buy → Neutral
Sep-30-20 Initiated Atlantic Equities Overweight
Sep-29-20 Downgrade Wolfe Research Outperform → Peer Perform
Sep-22-20 Downgrade Stifel Buy → Hold
Sep-22-20 Downgrade UBS Buy → Neutral
Sep-21-20 Upgrade Guggenheim Neutral → Buy
Sep-21-20 Downgrade JP Morgan Overweight → Neutral
Sep-09-20 Initiated Morgan Stanley Equal-Weight
Aug-07-20 Downgrade Evercore ISI In-line → Underperform
Aug-07-20 Downgrade Piper Sandler Overweight → Neutral
Jul-07-20 Downgrade Guggenheim Buy → Neutral
Apr-24-20 Downgrade Citigroup Buy → Neutral
Apr-21-20 Downgrade Robert W. Baird Outperform → Neutral
Jan-08-20 Initiated Wells Fargo Underweight
Jan-07-20 Initiated Citigroup Buy
Jan-02-20 Downgrade Evercore ISI Outperform → In-line
Nov-15-19 Initiated Stifel Buy
Oct-25-19 Initiated Guggenheim Buy
View All

Illumina Inc Stock (ILMN) Latest News

pulisher
06:09 AM

Illumina Inc (ILMN) CEO Jacob Thaysen Increases Stake with Recen - GuruFocus

06:09 AM
pulisher
04:05 AM

Illumina Leadership to Share Strategic Vision at Prestigious Bernstein Conference May 28 - Stock Titan

04:05 AM
pulisher
10:55 AM

Illumina unveils DRAGEN version 4.4 software focusing on oncology applications for clinical research - BioSpectrum India

10:55 AM
pulisher
07:49 AM

Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying - Insider Monkey

07:49 AM
pulisher
04:37 AM

South East Asia Molecular Diagnostics Market Forecast to 2031: PCR Technology Leads Growth, Kits & Reagents Hold Largest Share - GlobeNewswire Inc.

04:37 AM
pulisher
03:36 AM

Onco-hematology Molecular Testing Market Top Players - openPR.com

03:36 AM
pulisher
May 13, 2025

Championing greater health in and outside the office - Illumina

May 13, 2025
pulisher
May 13, 2025

NGS Library Preparation Market Growth Projections | Key Players: Illumina, Thermo Fisher Scientific, Roche - openPR.com

May 13, 2025
pulisher
May 13, 2025

Illumina unveils DRAGEN v4.4 with enhanced accuracy - Investing.com

May 13, 2025
pulisher
May 13, 2025

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications - Illumina

May 13, 2025
pulisher
May 13, 2025

Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue Trends - Yahoo Finance

May 13, 2025
pulisher
May 13, 2025

Illumina, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - simplywall.st

May 13, 2025
pulisher
May 13, 2025

Illumina, Inc. Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

May 13, 2025
pulisher
May 12, 2025

Illumina Faces Uncertainties From China Ban, Research Slump, Morgan Stanley Says - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Morgan Stanley Adjusts Illumina Price Target to $100 From $136, Maintains In Line Rating - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

Functional Genomics Market Top PlayersExact Sciences - openPR.com

May 12, 2025
pulisher
May 12, 2025

Canaccord cuts Illumina stock target to $87, maintains hold By Investing.com - Investing.com India

May 12, 2025
pulisher
May 12, 2025

Canaccord cuts Illumina stock target to $87, maintains hold - Investing.com

May 12, 2025
pulisher
May 12, 2025

Illumina Q1 2025 revenue down 1% to USD 1.04 billion - Medical Buyer

May 12, 2025
pulisher
May 11, 2025

Illumina outlines $4.18B to $4.26B guidance for 2025 amid China headwinds and strategic cost reductions - MSN

May 11, 2025
pulisher
May 10, 2025

Illumina: Multiple Headwinds Point To Limited Upside In 2025 (NASDAQ:ILMN) - Seeking Alpha

May 10, 2025
pulisher
May 10, 2025

Illumina (ILMN) Faces Adjusted Price Target and Positive Earnings Outlook | ILMN Stock News - GuruFocus

May 10, 2025
pulisher
May 10, 2025

Illumina, Inc. (NASDAQ:ILMN) Q1 2025 Earnings Call Transcript - Insider Monkey

May 10, 2025
pulisher
May 09, 2025

Cathie Wood’s ARK buys Shopify, Illumina stock; sells Palantir, Natera - Investing.com

May 09, 2025
pulisher
May 09, 2025

Cathie Wood’s ARK buys Shopify, Illumina stock; sells Palantir, Natera By Investing.com - Investing.com India

May 09, 2025
pulisher
May 09, 2025

Illumina (ILMN) Price Target Lowered by JP Morgan | ILMN Stock N - GuruFocus

May 09, 2025
pulisher
May 09, 2025

SEC ends probe of Illumina’s Grail acquisition - MedTech Dive

May 09, 2025
pulisher
May 09, 2025

TD Cowen raises Illumina stock target to $89, maintains Hold rating - Investing.com

May 09, 2025
pulisher
May 09, 2025

Precision Medicine Market Analysis Report 2024-2030: Bristol-Myers Squibb, Illumina, Merck, AstraZeneca, and Roche Dominate with their Contributions to Research, Product Approvals, and Partnerships - GlobeNewswire

May 09, 2025
pulisher
May 09, 2025

Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips - Yahoo Finance

May 09, 2025
pulisher
May 09, 2025

Illumina Q1 2025 slides: Revises guidance downward amid China restrictions and tariff impacts - Investing.com

May 09, 2025
pulisher
May 09, 2025

Lab-on-a-Chip Market Insights: Growth, Trends & Forecast - openPR.com

May 09, 2025
pulisher
May 09, 2025

Illumina Inc (ILMN) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... By GuruFocus - Investing.com Canada

May 09, 2025
pulisher
May 09, 2025

Earnings call transcript: Illumina Q1 2025 beats EPS forecast but faces stock dip - Investing.com

May 09, 2025
pulisher
May 09, 2025

Illumina Reports Q1 2025 Financial Results Amid Challenges - TipRanks

May 09, 2025
pulisher
May 08, 2025

Illumina: Q1 Earnings Snapshot - Norwalk Hour

May 08, 2025
pulisher
May 08, 2025

Illumina (ILMN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Illumina confirms SEC has closed investigation into $8B Grail deal - Endpoints News

May 08, 2025
pulisher
May 08, 2025

Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Illumina (ILMN) Shares Drop 3% Despite Beating Q1 EPS Estimates - GuruFocus

May 08, 2025
pulisher
May 08, 2025

Illumina’s (NASDAQ:ILMN) Q1 Sales Top Estimates - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Illumina down 3% as lowered 2025 EPS guidance overshadows Q1 top-line beat - MSN

May 08, 2025
pulisher
May 08, 2025

Illumina Cuts Guidance on Threat From Tariffs and China Ban - Bloomberg

May 08, 2025
pulisher
May 08, 2025

Digital Genome Market Forecast: Growth Trends, Key Players & - openPR.com

May 08, 2025
pulisher
May 08, 2025

Illumina Reports Financial Results for First Quarter of Fiscal Year 2025 - PR Newswire

May 08, 2025
pulisher
May 08, 2025

Lobbying Update: $620,000 of ILLUMINA INC. lobbying was just disclosed - Nasdaq

May 08, 2025
pulisher
May 08, 2025

Clinical Oncology Next-Generation Sequencing Market Size, - openPR.com

May 08, 2025
pulisher
May 08, 2025

INVESTOR ALERT: Levi & Korsinsky Notifies Shareholders of Illumina, Inc.(ILMN) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire

May 08, 2025
pulisher
May 07, 2025

Single Cell Genome Sequencing Market Deep Research 2025-2032 | - openPR.com

May 07, 2025
pulisher
May 06, 2025

ILLUMINA Earnings Preview: Recent $ILMN Insider Trading, Hedge Fund Activity, and More - Nasdaq

May 06, 2025
pulisher
May 06, 2025

Here’s Why Artisan Mid Cap Fund Decided to Exit Illumina (ILMN) - Insider Monkey

May 06, 2025

Illumina Inc Stock (ILMN) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research DGX
$172.48
price down icon 1.15%
diagnostics_research WAT
$345.38
price down icon 3.80%
diagnostics_research LH
$242.37
price down icon 3.06%
$151.34
price down icon 0.62%
diagnostics_research MTD
$1,117.81
price down icon 5.03%
diagnostics_research IQV
$141.82
price down icon 5.88%
Cap:     |  Volume (24h):